FUNDING SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring

10-25 leads daily

Real-time alerts

★★★★★

4.8/5 on G2• High Performer Fall 2025

Used by teams at LinkedIn, HubSpot & Oracle

🔒 app.fundz.net

TechCorp

📍 San Francisco👥 85

Post-Funding

⭐ Ideal Match

Just raised $40M Series B - high purchase intent window

Proto Kinetix, Inc. announced it raised $110,000 in an initial filing from an offering of $325,000

Jan 14, 2019•over 6 years ago

Amount Raised

$110,000

DaltonBiotechnology

Company Information

Company

ProtoKinetix

Location

109 W. MAIN ST.

Dalton, Ohio, United States

About

ProtoKinetix (PKTX) is a research and development company leading the way in cell survival solutions. Its patented anti-aging glycopeptide (AAGP) is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide helps more cells survive longer and has the capability to change health care forever.

FundzWatch™ Score

100

High Activity

55 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech